Despite the spikes of COVID-19 cases in California, UC San Diego has successfully curtailed outbreaks through a combination of strategic public health interventions driven by the university’s Return to Learn program.
UC San Diego’s nationally recognized, evidence-based Return to Learn program employs a comprehensive suite of education, monitoring, testing, intervention and notification tools that no other university is using. And the program continues to expand.
A team fielded for the first time by SDSC and UC San Diego achieved 4th place overall out of 19 teams in the Student Cluster Competition, held during the annual Supercomputing Conference (SC20).
How did use of massive tents to enable students to learn outdoors take shape, what technology is available and which classes will be taught outdoors? To answer these and other questions, we spoke with Carlos Jensen, associate vice chancellor of Education Innovation at UC San Diego.
As part of the Return to Learn program, we invited students to submit their questions about how to safely socialize on campus, what happens if residential students must travel off-campus for an extended period, outdoor recreation classes offered, study spaces available and more.
As part of the Return to Learn program, UC San Diego’s campus privacy officer, Pegah Parsi addresses questions from students, faculty and staff about how student and employee health records are protected, what information is stored, who is informed of test results and more.
They are working as peer mentors to veteran students. Some are studying medicine are practicing performing exams on patients. UC San Diego’s record-setting population of more than 40,000 students are working toward their degree this fall with a hybrid of in-person and remote instruction.
We spoke with Terri Winbush, senior director of Labor Relations and Employee Relations for the main campus about what paid leave options are available, what happens when an employee receives a yellow or red thumb on the daily symptom screening, and the remote support employees can access.
School of Medicine experts Dr. Susan Little and Dr. Stephen A. Spector share more about how the UC San Diego community can get involved in the latest vaccine trials, when a vaccine may be approved, and how the vaccines are designed to produce antibodies.